Lenomorelin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Lenomorelin
Accession Number
DB11895
Type
Biotech
Groups
Investigational
Biologic Classification
Protein Based Therapies
Other protein based therapies
Description

Lenomorelin has been investigated for the treatment and basic science of Cancer, Alcoholism, Metabolism, Hypopituitarism, and Frailty Syndrome, among others.

Protein chemical formula
Not Available
Protein average weight
Not Available
Sequences
Not Available
Synonyms
  • Ghrelin
  • Ghrelin (human)
  • Ghrelin human
  • Human ghrelin
  • Lenomorelin
Product Ingredients
IngredientUNIICASInChI Key
Lenomorelin acetate4492AYV7VONot AvailableNot applicable
Categories
UNII
UXG268Q86R
CAS number
258279-04-8

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347911255
Wikipedia
Ghrelin

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
0Active Not RecruitingOtherAlcohol Dependence / BMI >30 kg/m2 / Cessation, Smoking1
0CompletedBasic ScienceHealthy Volunteers1
1Active Not RecruitingBasic ScienceBMI >30 kg/m21
1CompletedBasic ScienceBMI >30 kg/m21
1CompletedBasic ScienceBMI >30 kg/m2 / Insulin Resistance / Normal Weight,Healthy Controls1
1CompletedBasic ScienceHealthy Controls1
1CompletedBasic ScienceHealthy Volunteers1
1CompletedBasic ScienceNormal Healthy Volunteers1
1CompletedBasic ScienceType 2 Diabetes Mellitus1
1CompletedTreatmentHealthy Volunteers1
1RecruitingBasic ScienceRenal Tubular Transport1
1WithdrawnHealth Services ResearchBMI >30 kg/m2 / Healthy Volunteers1
1, 2CompletedOtherFrailty1
1, 2CompletedTreatmentCachexia / Cancer, Advanced1
1, 2CompletedTreatmentPAD / Peripheral Arterial Disease (PAD) / Peripheral Artery Disease (PAD)1
2CompletedOtherAlcohol Dependence / Alcohol Drinking / FMRI1
2CompletedOtherFrailty Syndrome1
2CompletedOtherThe Frailty Syndrome1
2CompletedTreatmentFrailty in Aging1
2Not Yet RecruitingTreatmentPeripheral Artery Disease (PAD)1
2TerminatedTreatmentParkinson's Disease (PD)1
3CompletedTreatmentMalignancies1
Not AvailableCompletedNot AvailableAlcohol Dependence1
Not AvailableCompletedBasic ScienceBMI >30 kg/m2 / Healthy Volunteers1
Not AvailableCompletedBasic ScienceHealthy Volunteers / Major Depressive Disorder (MDD)1
Not AvailableCompletedBasic ScienceHypopituitarism / Insulin Resistance / Metabolism1
Not AvailableCompletedTreatmentHealthy Volunteers1
Not AvailableCompletedTreatmentHypopituitarism1
Not AvailableUnknown StatusNot AvailableThe Diabetic Process1
Not AvailableUnknown StatusBasic ScienceDiabetes1
Not AvailableUnknown StatusHealth Services ResearchCystic Fibrosis (CF)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available

Drug created on October 20, 2016 14:58 / Updated on March 01, 2020 23:46

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates